Daebongls.Co.Ltd
Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company's Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju hatban extract, wormwood extract, jeju camellia oil, jeju dang oil extract, jeju basalt po… Read more
Market Cap & Net Worth: Daebongls.Co.Ltd (078140)
Daebongls.Co.Ltd (KQ:078140) has a market capitalization of $77.84 Million (₩113.97 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22558 globally and #1158 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daebongls.Co.Ltd's stock price ₩10280.00 by its total outstanding shares 11086600 (11.09 Million).
Daebongls.Co.Ltd Market Cap History: 2015 to 2026
Daebongls.Co.Ltd's market capitalization history from 2015 to 2026. Data shows change from $72.03 Million to $77.84 Million (-0.48% CAGR).
Index Memberships
Daebongls.Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #558 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #558 of 1384 |
Weight: Daebongls.Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Daebongls.Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daebongls.Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Daebongls.Co.Ltd's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
Daebongls.Co.Ltd's market cap is 0.01 times its annual earnings
0.18x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $72.03 Million | $58.65 Billion | $7.15 Billion | 0.00x | 0.01x |
| 2016 | $85.89 Million | $71.04 Billion | $8.39 Billion | 0.00x | 0.01x |
| 2017 | $70.90 Million | $65.65 Billion | $7.14 Billion | 0.00x | 0.01x |
| 2018 | $46.43 Million | $71.82 Billion | $6.22 Billion | 0.00x | 0.01x |
| 2019 | $50.85 Million | $69.54 Billion | $5.73 Billion | 0.00x | 0.01x |
| 2020 | $82.55 Million | $76.25 Billion | $5.82 Billion | 0.00x | 0.01x |
| 2021 | $62.92 Million | $82.96 Billion | $6.79 Billion | 0.00x | 0.01x |
| 2022 | $60.16 Million | $93.50 Billion | $8.63 Billion | 0.00x | 0.01x |
| 2023 | $69.36 Million | $87.62 Billion | $4.18 Billion | 0.00x | 0.02x |
| 2024 | $101.76 Million | $93.95 Billion | $7.34 Billion | 0.00x | 0.01x |
Competitor Companies of 078140 by Market Capitalization
Companies near Daebongls.Co.Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Daebongls.Co.Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
Daebongls.Co.Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Daebongls.Co.Ltd's market cap moved from $72.03 Million to $ 77.84 Million, with a yearly change of -0.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩77.84 Million | -11.76% |
| 2025 | ₩88.21 Million | -13.32% |
| 2024 | ₩101.76 Million | +46.72% |
| 2023 | ₩69.36 Million | +15.29% |
| 2022 | ₩60.16 Million | -4.40% |
| 2021 | ₩62.92 Million | -23.78% |
| 2020 | ₩82.55 Million | +62.33% |
| 2019 | ₩50.85 Million | +9.52% |
| 2018 | ₩46.43 Million | -34.51% |
| 2017 | ₩70.90 Million | -17.46% |
| 2016 | ₩85.89 Million | +19.25% |
| 2015 | ₩72.03 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Daebongls.Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $77.84 Million USD |
| MoneyControl | $77.84 Million USD |
| MarketWatch | $77.84 Million USD |
| marketcap.company | $77.84 Million USD |
| Reuters | $77.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.